Pages that link to "Q42552411"
Jump to navigation
Jump to search
The following pages link to Effects of lamivudine on replication of hepatitis B virus in HIV-infected men. (Q42552411):
Displaying 50 items.
- Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine (Q28372760) (← links)
- Role of lamivudine in the treatment of chronic hepatitis B virus infection (Q28375031) (← links)
- Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients (Q28375088) (← links)
- Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: characterization of genotype G in Brazil (Q33315735) (← links)
- Lamivudine. A review of its therapeutic potential in chronic hepatitis B. (Q33706739) (← links)
- YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitro full-length viral DNA transfection (Q33853661) (← links)
- Management of viral hepatitis B. (Q33959006) (← links)
- Viral hepatitis A, B, and C. (Q34170425) (← links)
- Drug discovery and development of antiviral agents for the treatment of chronic hepatitis B virus infection. (Q34363078) (← links)
- Management of chronic viral hepatitis in HIV-infected patients: Spanish Consensus Conference. October 2000. (Q34614976) (← links)
- A preliminary benefit-risk assessment of lamivudine for the treatment of chronic hepatitis B virus infection (Q34716850) (← links)
- Hepatitis B virus resistance to lamivudine and its clinical implications (Q35007583) (← links)
- Clinical and virological aspects of hepatitis B co-infection in individuals infected with human immunodeficiency virus type-1. (Q35071452) (← links)
- Management of Hepatitis B and C in HIV Co-Infected Patients (Q35561366) (← links)
- Treatment of chronic hepatitis B virus infection in patients co-infected with human immunodeficiency virus (Q35621741) (← links)
- A treatment algorithm for the management of chronic hepatitis B virus infection in the United States (Q35689607) (← links)
- Management of hepatitis B in patients coinfected with the human immunodeficiency virus. (Q35757754) (← links)
- Review article: Nucleoside analogues for the treatment of chronic hepatitis B. (Q35987869) (← links)
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update (Q36135493) (← links)
- Treatment options in HBV. (Q36342873) (← links)
- Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative study (Q36698116) (← links)
- Living donor liver transplantation for hepatitis B cirrhosis (Q37010424) (← links)
- Evaluation and treatment of the patient coinfected with hepatitis B and HIV. (Q37216879) (← links)
- Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1-hepatitis B virus coinfected individuals: similar effectiveness of lamivudine, tenofovir, or combination therapy (Q37287635) (← links)
- Hepatitis B Infection: What The Primary Care Doctors Should Know (Q38782898) (← links)
- Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus (Q39451785) (← links)
- In vitro anti-human immunodeficiency virus and anti-hepatitis B virus activities and pharmacokinetic properties of heterodinucleoside phosphates containing AZT or ddC. (Q40983950) (← links)
- Robustaflavone, a potential non-nucleoside anti-hepatitis B agent (Q40996541) (← links)
- Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin (Q42540557) (← links)
- Long-term therapy for chronic hepatitis B in HIV co-infected patients (Q42795326) (← links)
- Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis. (Q43264432) (← links)
- Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study (Q43599844) (← links)
- Failure of combination therapy with lamivudine and famciclovir following lamivudine monotherapy for hepatitis B virus infection in patients coinfected with human immunodeficiency virus-1. (Q43792563) (← links)
- Role of interferons in the treatment of hepatitis B and hepatitis C virus infections (Q44248571) (← links)
- Frequent occult hepatitis B virus infection in patients infected with human immunodeficiency virus type 1. (Q44355838) (← links)
- Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients. (Q44441066) (← links)
- Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002-2003. (Q44496767) (← links)
- Dynamics of plasma hepatitis B virus levels after highly active antiretroviral therapy in patients with HIV infection (Q44671785) (← links)
- Fatal interruption of a 3TC-containing regimen in a HIV-infected patient due to re-activation of chronic hepatitis B virus infection (Q45015757) (← links)
- Developing strategies for prevention and treatment of recurrent HBV in liver transplantation (Q45286354) (← links)
- Liver transplantation for hepatitis B virus patients: long-term results of three therapeutic approaches (Q45392363) (← links)
- Early emergence of entecavir-resistant hepatitis B virus in a patient with hepatitis B virus/human immunodeficiency virus coinfection (Q45398766) (← links)
- Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: high prevalence of occult infection and low frequency of lamivudine resistant mutations (Q45410863) (← links)
- Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients (Q45419512) (← links)
- HIV and Hepatitis Virus Infection (Q45739561) (← links)
- A placebo-controlled phase I/II study of adefovir dipivoxil in patients with chronic hepatitis B virus infection (Q45745544) (← links)
- Emergence of YMDD motif mutants of hepatitis B virus during lamivudine treatment of immunocompetent type B hepatitis patients (Q45746181) (← links)
- Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy (Q45747018) (← links)
- Absence of mutations in the YMDD motif/B region of the hepatitis B virus polymerase in famciclovir therapy failure (Q45748929) (← links)
- Human immunodeficiency virus infection, Part I. (Q45752854) (← links)